Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health    CVS

CVS HEALTH (CVS)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Sales139 367153 290177 526183 991192 713203 209
EBITDA10 60411 90813 05312 57513 02313 574
Operating profit (EBIT)9 19110 42711 37310 05110 38710 789
Pre-Tax Profit (EBT)------
Net income4 6445 2375 3175 2665 6306 011
P/E ratio24,321,116,115,113,111,8
EPS ( $ )3,964,634,905,065,826,49
Dividend per Share ( $ )1,101,401,701,952,202,60
Yield1,14%1,43%2,15%2,55%2,88%3,39%
Reference price ( $ )96.3197.7778.9176.4976.4976.49
Announcement Date02/10/2015
12:00pm
02/09/2016
11:51am
02/09/2017
11:55am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Debt10 44024 91724 07324 75024 71024 286
Finance------
Operating income (EBITDA)10 60411 90813 05312 57513 02313 574
Leverage
(Debt/EBITDA)
0,98x2,09x1,84x1,97x1,90x1,79x
Capital Expenditure2 1362 3672 2242 1312 2352 168
Book Value Per Share (BVPS)33,3 $33,8 $34,7 $34,8 $35,7 $37,0 $
Cash Flow per Share6,96 $7,47 $9,33 $9,15 $10,0 $11,4 $
Announcement Date02/10/2015
12:00pm
02/09/2016
11:51am
02/09/2017
11:55am
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 77 757 M$ -
Entreprise Value (EV) 102 507 M$ 102 467 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 15,1x 13,1x
Capitalization / Revenue 0,42x 0,40x
EV / Revenue 0,56x 0,53x
EV / EBITDA 8,15x 7,87x
Yield (DPS / Price) 2,55% 2,88%
Price to book (Price / BVPS) 2,20x 2,14x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 5,46% 5,39%
operating Leverage (Delta EBIT / Delta Sales) - 0,70x
Net Margin (Net Profit / Revenue) 2,86% 2,92%
ROA (Net Profit / Asset) 7,37% 7,74%
ROE (Net Profit / Equities) 15,4% 16,8%
Rate of Dividend 38,5% 37,8%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   1,16% 1,16%
Cash Flow / Sales 5,05% 5,30%
Capital Intensity (Assets / Sales) 0,39x 0,38x
Financial Leverage (Net Debt / EBITDA) 1,97x 1,90x
EPS & Dividend